News
Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...
Eli Lilly and Purdue University announced a $250 million in what the two institutions say is the largest industry-academic partnership in the country.
Eli Lilly and Co. and Purdue University on Friday announced an expanded collaboration agreement, with the Indianapolis ...
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...
Representatives from Eli Lilly, Cook Medical and other Hoosier businesses gave advice about tariffs during the Indiana ...
Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...
The 500 Festival announces winners of the Employee Wellness Challenge and Badge Match Challenge for 2025. Winners to display trophy at their workplace.
Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...
6h
The Healthy @Reader's Digest on MSN“Brunch with Babs” on Brain Health, Family Milestones, and How to Pamper MomsSocial media’s favorite grandma opens up about Alzheimer’s awareness, her wellness secrets, and the joy of keeping life ...
Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with ...
Eli Lilly and Purdue University are expanding their partnership to improve drug discovery and manufacturing with a commitment of up to $250 million.
Learn more about whether BioCryst Pharmaceuticals, Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results